-
Jun 18, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Kristen Campbell, PharmD, BCPS, CPP: Hi everyone, I am Kristen Bova Campbell. I am a clinical pharmacist at Duke University Hospital. Megan LaBreck, PharmD, BCPS, CACP: I am Megan LaBreck. I am a clinical pharmacist at OhioHealth Riverside in Columbus, Ohio. Campbell: Why don't you tell me a little about what you do in your role? LaBreck: I currently see patients in our outpatient Antiarrhythmic Clinic, and these patients are either new starts on antiarrhythmic drugs or continuations of therapy.
-
Jun 11, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of EP Lab Digest or HMP Global, their employees, and affiliates. In this discussion, Mark Link, MD, and Rachel Lampert, MD, discuss the newly released 2024 HRS expert consensus statement on arrhythmias in the athlete.
-
May 9, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Please introduce yourself and your focus of work. I'm Emily Murtagh, an electrophysiology (EP) technologist at St Paul's Hospital in Vancouver, Canada. I'm also an EP instructor at the British Columbia Institute of Technology and I'm vice chair of the HRS Core Concepts in EP Committee. What are some of the key challenges in the diagnosis, management, and treatment of PVCs? What can you tell us about the presentations being featured during the session you will be chairing?
-
May 9, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Please introduce yourself and your focus of work. My name is Rebecca Yapejian. I am an electrophysiology (EP) nurse practitioner. I have been in the world of EP for a little over 7 years now. The majority of that time was spent with Duke University Health System, where I got to learn from some of the greatest in EP.
-
May 1, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of EP Lab Digest or HMP Global, their employees, and affiliates. EP LAB DIGEST. 2024;24(5):10,12-13.
-
Apr 24, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of EP Lab Digest or HMP Global, their employees, and affiliates. EP LAB DIGEST. 2024;24(5):18,20. In this feature interview, EP Lab Digest talks with Chirag Barbhaiya, MD, about his initial experience and first-in-human cases using the new MATRIX12 M probe (CIRCA Scientific, Inc) (Figure 1).
-
Apr 17, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
What will you be discussing today? Tell us about your presentation at Western AF. Today, I went over the top 10 highlights of the ACC/AHA/ACCP/HRS AF management guidelines. We went over some of the highlights, which include a new staging system of AF that includes 2 stages before the diagnosis of AF, allowing us to focus on a stage at which patients may be at risk for AF because they have reversible or non-reversible risk factors for AF.
-
Apr 15, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
What can you tell us about your presentation today at Western AF? What Nassir asked me to speak about this year was on the topic of if we are ready to consider outpatient ablation of AF to be the standard of care. I will take people through the journey and evolution of the procedure, how procedure times have become shorter, and postprocedural care has become shorter. All these things really lend themselves well to an outpatient procedure.
-
Apr 6, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
What has been your personal exposure to PFA during its development in the United States and elsewhere? We have been fortunate to be part of the different PFA studies at TCA in Austin, so we have been able to participate in different technologies and enroll patients in the clinical studies. With commercial approval, we have been able to start doing procedures commercially in our lab in Austin. What are the main pros and cons to PFA compared to thermal devices for AF ablation?
-
Mar 28, 2024 | 
hmpgloballearningnetwork.com | Jodie Elrod
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of EP Lab Digest or HMP Global, their employees, and affiliates. In the wake of the COVID-19 pandemic and the release of the 2023 Heart Rhythm Society (HRS) guidelines, device clinic managers face extraordinary challenges in adapting to evolving healthcare landscapes.
